Skip to main content
Clinical Trials/JPRN-UMIN000050152
JPRN-UMIN000050152
Completed
未知

Clinical study to confirm anti-sarcopenia effect of test food. - Clinical study to confirm anti-sarcopenia effect of test food.

EP Mediate Co., Ltd0 sites50 target enrollmentJanuary 30, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
EP Mediate Co., Ltd
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 30, 2023
End Date
August 10, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Subjects (1\) who have or have a history of any disease that may affect the evaluation of the study (2\) who have difficulty in daily activities or walking due to severe pain, or who are unable to perform exercise training (3\) diagnosed with sarcopenia (4\) who have a possibility of recurrence of locomotory disease due to exercise training (5\) who regularly use health foods that may affect the evaluation of the study (6\) who regularly use pharmaceuticals (7\) who exercise regularly (8\) who exercise excessively (9\) with a history of locomotory disease within 1 year before the screening examination (10\) who use canes or supporters (11\) who periodically conduct actions that may affect the evaluation of effectiveness (12\) who are under treatment of diseases on the joints (13\) who have or have a history of severe diseases (14\) who are under treatment or have a history of mental diseases (15\) who have unsteady lifestyle or who work manual labor (16\) who drink a lot (17\) who have possibilities for emerging allergy onset related to the study (18\) who are judged as unsuitable for the study based on the results of screening examination (19\) who have participated in other clinical study within a month before the screening test or who intend to participate in the study period (20\) who are in a pregnancy or lactation period in the study period (21\) who are judged as unsuitable due to lifestyle questionnaire (22\) who cannot carry out the test as instructed (23\) who are judged as unsuitable for the study by investigator for other reasons

Outcomes

Primary Outcomes

Not specified

Similar Trials